Repare Therapeutics Inc
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About RPTX
Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.
Find out what a historical investment in Repare Therapeutics Inc would be worth today using our RPTX stock calculator.
$64.34M
-
0.00%
206
$1.58
$1.43
$0.00
$4.29
$0.89
Ready to start your investing journey with Stake?
Open an accountRPTX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RPTX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RPTX
on Stake
Buy RPTX from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of RPTX from only US$10 with fractional shares
